Guangdong Hybribio Biotech Co.,Ltd.
Status: Publicly traded
Direct answer
Guangdong Hybribio Biotech Co.,Ltd. is publicly traded on SHZ under the ticker 300639.SZ.
Founded in 2003 and headquartered in Sheung Wan, Hong Kong, Guangdong Hybribio Biotech Co.,Ltd. specializes in the research, development, and commercialization of nucleic acid-based molecular diagnostic solutions. The company caters to hospitals and medical facilities, providing a comprehensive range of in-vitro diagnostic (IVD) kits. These kits target various health concerns, including human papillomavirus (HPV),...
Can you invest in Guangdong Hybribio Biotech Co.,Ltd.?
Yes. Guangdong Hybribio Biotech Co.,Ltd. is publicly traded on SHZ under the ticker 300639.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Guangdong Hybribio Biotech Co.,Ltd.
Detailed equity research is provided by MarketSnap.